YOLANDA VALDES: Open Payments
NPI 1134467483 · LIVE OAK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$953 in 42 payments from 16 companies in 2025. Trend: 2023 $1,477 · 2024 $1,615 · 2025 $953
Food & beverage: $953
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $202 |
| AstraZeneca Pharmaceuticals LP | 2 | $144 |
| Novo Nordisk Inc | 6 | $110 |
| Amgen Inc. | 4 | $84 |
| Lilly USA, LLC | 3 | $63 |
| Novartis Pharmaceuticals Corporation | 4 | $61 |
| PFIZER INC. | 3 | $57 |
| Inspire Medical Systems, Inc. | 2 | $45 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
Products named: Kerendia, BREZTRI, Wegovy, OTEZLA, MOUNJARO, ELIQUIS, INSPIRE, LEQVIO.
Industry payments across TX — which companies pay providers there.
